BioSpace News Archive

IRX Therapeutics Announces Presentation of IRX-2 Phase Ib Biomarker Data in Early Stage Breast Cancer

The results will be presented on Saturday, November 11 at the Society for Immunotherapy of Cancer’s (SITC) 31st Annual Meeting.

November 10, 2017
·
4 min read
Business

Myriad Collaborates With Department of Veterans Affairs in Large Trial Evaluating the GeneSight Test to Improve Mental Health Outcomes for Veterans

The 2,000 patient study will leverage GeneSight test to guide therapy selection.

November 10, 2017
·
9 min read
Business

Bone Therapeutics Business Update for Third Quarter 2017

Cash used in operating activities amounted to EUR 10.13 million for the first nine months of 2017, compared to EUR 8.95 million for the same period in 2016.

November 10, 2017
·
6 min read
BioCapital

India Globalization Capital Regains NYSE American Listing Compliance

The Company’s continued listing eligibility will continue to be assessed on an ongoing basis.

November 10, 2017
·
1 min read
Business

Kamada Announces Nomination of Three New Members to its Board of Directors

The new nominees will stand for election at Kamada’s 2017 Annual General Meeting of Shareholders on November 30, 2017 (the “AGM”).

November 10, 2017
·
5 min read
FDA

Teligent Announces FDA Approval of Betamethasone Dipropionate Ointment USP (Augmented), 0.05%

This is Teligent’s seventh approval for 2017.

November 10, 2017
·
2 min read
Vilacto Bio in Final Stage of Developing Anti-Aging Products

The company is extremely hopeful with the results observed so far with its new product line, and is anxious to launch pending the final quality tests.

November 10, 2017
·
2 min read
Business

MediciNova Announces Collaboration With the U.S. Department of Veterans Affairs and Oregon Health & Science University to Evaluate MN-166 (ibudilast) in Methamphetamine Use Disorder

The proposed clinical trial will evaluate MN-166 (ibudilast) as a potential treatment for individuals diagnosed with MA use disorder with or without post-traumatic stress disorder.

November 10, 2017
·
8 min read
BioCapital

Sucampo to Host 2017 R&D Day on November 16 in New York

Sucampo will highlight its two Phase 3 rare and orphan drug programs in Niemann-Pick Disease Type C1 (NPC-1) and Familial Adenomatous Polyposis (FAP).

November 10, 2017
·
4 min read
Ablynx: Publication in Accordance With Article 14 of The Belgian Law of 2 May 2007 Regarding The Publication of Major Shareholdings (The “Transparency Law”) - Nov. 10, 2017

The company received a notification of shareholdings from Millennium Group Management LLC on 7 November 2017.

November 10, 2017
·
4 min read